Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 8, 2019 Off

Primary Immune Deficiency (PID) Therapeutics Pipeline Review, H1 2019 Edition – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Primary Immune Deficiency (PID) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Primary…

ReViral Announces Grant of Key US Composition of Matter Patent for Their Respiratory Syncytial Virus Inhibitor Programme
April 8, 2019 Off

ReViral Announces Grant of Key US Composition of Matter Patent for Their Respiratory Syncytial Virus Inhibitor Programme

By BusinessWire

Patent claims RSV fusion protein inhibitors as medicines including lead pipeline candidate, RV521; patent nominally expires in 2035 (unextended) The…

Turning Point Therapeutics Appoints Annette North as Executive Vice President and General Counsel
April 8, 2019 Off

Turning Point Therapeutics Appoints Annette North as Executive Vice President and General Counsel

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company developing novel drugs that address treatment resistance, announced today…

Applied DNA Subsidiary LineaRx Achieves Biotech Industry First with Anti-CD19 Expression in Human CAR T Cells via Proprietary Non-Viral, Plasmid-Free Platform
April 8, 2019 Off

Applied DNA Subsidiary LineaRx Achieves Biotech Industry First with Anti-CD19 Expression in Human CAR T Cells via Proprietary Non-Viral, Plasmid-Free Platform

By BusinessWire

Novel DNA Manufacturing Platform Seeks to Pioneer New Generation of Faster, More Affordable Cell-based Therapeutics for Patients STONY BROOK, N.Y.–(BUSINESS…

April 8, 2019 Off

Avellino Labs Welcomes James (Jim) V. Mazzo to Its Board of Directors

By BusinessWire

MENLO PARK, Calif.–(BUSINESS WIRE)–Avellino Labs, global biotechnology and genetic science innovators, announced the strategic addition of James (Jim) V. Mazzo…

April 8, 2019 Off

Deep Lens Closes $14 Million Series A Financing to Further Advance Digital AI Pathology Platform for Clinical Trial Recruitment

By BusinessWire

COLUMBUS, Ohio–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AI?src=hash" target="_blank"gt;#AIlt;/agt;–Deep Lens, Inc., an AI-driven digital pathology company focused on clinical trial recruitment at the time…

Devonian Health Group Announces the Publication of Results of in Vitro Assessment of the Antioxidant and UV Protection Properties of Thylakoid Extracts in Journal of Cosmetic Dermatology.
April 8, 2019 Off

Devonian Health Group Announces the Publication of Results of in Vitro Assessment of the Antioxidant and UV Protection Properties of Thylakoid Extracts in Journal of Cosmetic Dermatology.

By BusinessWire

QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on developing…

April 8, 2019 Off

Global $3.67B Smart Inhalers Market, 2026: Key Industry Insights & Projections – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Smart Inhalers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and…

April 8, 2019 Off

Amneal to Report First Quarter 2019 Results on May 9, 2019

By BusinessWire

BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) will release its first quarter 2019 financial results on Thursday, May 9, 2019,…

April 8, 2019 Off

Schrödinger Receives Clinical-Stage Milestone Payment from Sanofi Collaboration

By BusinessWire

NEW YORK–(BUSINESS WIRE)–Schrödinger today announced receipt of a milestone payment from Sanofi (EURONEXT: SAN, NASDAQ: SNY) to mark the advancement…

Posts pagination

Previous 1 … 3,292 3,293 3,294 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine